An update on brivaracetam for the treatment of pediatric partial epilepsy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An update on brivaracetam for the treatment of pediatric partial epilepsy

Published:2021-05-12 Issue:11 Volume:22 Page:1387-1395
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Tulli Eleonora¹,Di Cara Giuseppe¹,Iapadre Giulia²,Striano Pasquale³⁴^ORCID,Verrotti Alberto¹

Affiliation:

1. Department of Pediatrics, University of Perugia, Perugia, Italy

2. Department of Pediatrics, University of L’Aquila, L’Aquila, Italy

3. Pediatric Neurology and Muscolar Diseases Unit, IRRCS Istituto Giannina Gaslini, Genova, Italy

4. Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2021.1921151

Reference67 articles.

1. Stereochemistry of the Brivaracetam Diastereoisomers

2. New antiepileptic drugs that are second generation to existing antiepileptic drugs

3. Brivaracetam efficacy and safety in focal epilepsy

4. The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Pharmacological Therapies in the Treatment of Epilepsy in the Pediatric Population;Journal of Clinical Medicine;2024-06-18

2. The latest advances in the pharmacological management of focal epilepsies in children: a narrative review;Expert Review of Neurotherapeutics;2024-03-05

3. Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil;Neuroscience Bulletin;2023-10-28

4. Efficacy, tolerability and pharmacokinetic variability of brivaracetam in adults with difficult-to-treat epilepsy;Epilepsy Research;2022-07

5. Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine;Frontiers in Pharmacology;2022-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3